Amy Beth Vanduyn Sells 685 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 685 shares of the stock in a transaction that occurred on Monday, April 15th. The shares were sold at an average price of $22.86, for a total transaction of $15,659.10. Following the sale, the senior vice president now directly owns 119,010 shares of the company’s stock, valued at approximately $2,720,568.60. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Amy Beth Vanduyn also recently made the following trade(s):

• On Monday, April 8th, Amy Beth Vanduyn sold 3,354 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total transaction of $75,867.48.

Phreesia Stock Down 2.3 %

Shares of NYSE:PHR opened at $22.62 on Friday. The stock’s 50 day moving average is $24.40 and its 200-day moving average is $21.26. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $34.98. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, topping the consensus estimate of ($0.58) by $0.02. The firm had revenue of $95.00 million for the quarter, compared to the consensus estimate of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The business’s revenue was up 24.0% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.72) earnings per share. As a group, equities research analysts predict that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on PHR shares. Royal Bank of Canada restated a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a report on Thursday, March 21st. Raymond James restated an “outperform” rating and set a $30.00 target price (up previously from $25.00) on shares of Phreesia in a research report on Friday, March 15th. Barclays assumed coverage on Phreesia in a report on Wednesday, January 3rd. They issued an “overweight” rating and a $29.00 target price for the company. Truist Financial assumed coverage on Phreesia in a report on Monday, February 26th. They set a “buy” rating and a $35.00 price target on the stock. Finally, JMP Securities lifted their price objective on shares of Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a research note on Thursday, March 21st. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, Phreesia currently has a consensus rating of “Moderate Buy” and an average price target of $31.62.

Institutional Investors Weigh In On Phreesia

Institutional investors and hedge funds have recently made changes to their positions in the business. International Assets Investment Management LLC increased its holdings in Phreesia by 1,987.3% during the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after purchasing an additional 1,411 shares in the last quarter. Captrust Financial Advisors lifted its holdings in shares of Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after purchasing an additional 866 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Phreesia during the first quarter worth $43,000. State of Wyoming raised its position in Phreesia by 34.6% in the 2nd quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after buying an additional 493 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in Phreesia by 85.4% during the 3rd quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after acquiring an additional 1,445 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.